UNSPSC 51172156: Adiphenine hydrochloride

This classification denotes an antimuscarinic agent with the molecular formula C20H25NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 42B4PDY0AV, chemically known as trasentine, hydrochloride but more generally known as adiphenine hydrochloride, which bears US NIH Compound Identifier 2031. European Medicines Agency schedules Adiphenine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00305MIG.

Most nations, for tariff and trade purposes, schedule adiphenine hydrochloride under HS 29221980 and SITC 51461. As of Q4 2014, ADIPHENINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Adiphenine hydrochloride bears US NLM NCI C75271. SMILES: CCN(CC)CCOC(=O)C(C1CCCCC1)C2CCCCC2.CL.

UNSPSC 51172156 Adiphenine hydrochloride is a Commodity code that in recent state and local procurement activity covers pharmaceutical products and drug testing services procured by criminal justice, health, and cooperative purchasing entities. The code's scope extends beyond the single active pharmaceutical ingredient to encompass generic pharmaceuticals, over-the-counter products, and specimen collection with laboratory analysis under contracts that state and local agencies use to deliver public health, offender supervision, and employee health benefits. Issuing bodies include county criminal justice departments (Collin County Community Supervision and Corrections Department), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance administering contracts for participating state and local facilities across multiple states including Oregon). The procurement pattern shows both direct pharmaceutical supply contracts and service-based drug testing contracts where the acquisition vehicle is the primary decision point for vendors.

Recent activity concentrates in Texas and Minnesota. Collin County posted RFP 2026-327 on July 9, 2026 for offender specimen collection and drug testing services with proposals due July 23, 2026, covering staffing of two collection sites in Plano and McKinney, immunoassay screening with LC/MS/MS or GC/MS confirmation, and alternative testing methodologies, with an estimated contract value of $600,000 and a two-year term commencing September 1, 2026 with three optional one-year renewal periods. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 on January 20, 2026 with a March 26, 2026 deadline to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities, requiring vendors to supply through three authorized wholesalers with pricing weighted 75 percent in evaluation and effective July 1, 2026. The Texas HHS Commission posted RFI HHS0017013 on April 3, 2026 seeking market intelligence on direct-to-manufacturer prescription programs as a preliminary information-gathering phase before formal procurement.